SCHEMBL355292

SCHEMBL355292

CNC(=O)c1nnc(-c2ccccc2)o1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.63
SMN1; SMN2 Q16637 3/20 0.56
GAA P10253 2/20 0.56
ALDH1A1 P00352 2/20 0.56
HIF1A Q16665 1/20 0.56
HDAC6 Q9UBN7 2/20 0.54
NPC1 O15118 5/20 0.52
RAB9A P51151 5/20 0.52
PKM P14618 1/20 0.51
SMPD1 P17405 1/20 0.51
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.51
MAPT P10636 1/20 0.51
HPGD P15428 1/20 0.51
ALOX15 P16050 1/20 0.51
RECQL P46063 1/20 0.51
KMT2A Q03164 1/20 0.51
HSD17B10 Q99714 1/20 0.51
CES1 P23141 2/20 0.50
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15498835 0.83 PTPN1 (0.63) PTPN1SMN1; SMN2GAAALDH1A1HIF1A
SCHEMBL2357551 0.82 TSHR (0.65) PTPN1SMN1; SMN2GAAALDH1A1HIF1A
SCHEMBL3748633 0.81 PTPN1 (0.65) PTPN1SMN1; SMN2GAAALDH1A1HIF1A
SCHEMBL12831210 0.81 PTPN1 (0.69) PTPN1SMN1; SMN2GAAALDH1A1HIF1A
SCHEMBL2330752 0.80 PTPN1 (0.93) PTPN1SMN1; SMN2GAAALDH1A1HIF1A
SCHEMBL27790021 0.80 PTPN1 (0.73) PTPN1SMN1; SMN2GAAALDH1A1HIF1A
SCHEMBL19017805 0.80 NOTUM (0.48) PTPN1SMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL2329015 0.79 PTPN1 (0.89) PTPN1SMN1; SMN2GAAALDH1A1HIF1A
Hydrochloric Acid SCHEMBL19118776 0.79 PTPN1 (0.89) PTPN1SMN1; SMN2GAAALDH1A1HIF1A
SCHEMBL1222382 0.79 PTPN1 (0.89) PTPN1SMN1; SMN2GAAALDH1A1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443123-B1 SMALL MOLECULE INHIBITORS OF SPLEEN TYROSINE KINASE (SYK) RIGEL PHARMACEUTICALS INC (US) 2017-04-05 EP disclosed
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US disclosed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds NAAA, AADAC, RPSA PTPN1 4104/4885SMN1; SMN2 2356/4885GAA 602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.